Immunovant Inc

Stock Chart, Company Information, and Scan Results

$38.75(as of Sep 9, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Immunovant Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$38.75
Ticker SymbolIMVT
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees315
CountyUSA
Market Cap$8,107.2M
EBIDTA-565.6M
10-Day Moving Average40.58
P/E Ratio0.00
20-Day Moving Average42.03
Forward P/E Ratio0.00
50-Day Moving Average40.46
Earnings per Share-2.81
200-Day Moving Average30.72
Profit Margin0.00%
RSI37.45
Shares Outstanding206.6M
ATR1.53
52-Week High45.42
Volume1,023,513
52-Week Low14.58
Most Recent Support Level38.34
Book Value0.0M
Most Recent Resistance Level40.56
P/B Ratio0.00
Upper Keltner45.48
P/S Ratio0.00
Lower Keltner38.57
Debt-to-Equity Ratio0.00
Next Earnings DateUnknown
Cash Surplus0.0M
Next Ex-Dividend DateUnknown

Immunovant, Inc., a clinical-stage immunology company, develops targeted therapies to meet the needs of people with autoimmune diseases. It develops IMVT-1402, a human monoclonal antibody that inhibits neonatal fragment crystallizable receptor for graves' disease, rheumatoid arthritis, sjögren's disease, cutaneous lupus erythematosus disease, myasthenia gravis, and chronic inflammatory demyelinating polyneuropathy. The company was founded in 2018 and is based in Durham, North Carolina. Immunovant, Inc. operates as a subsidiary of Roivant Sciences Ltd.

Immunovant Inc In Our Stock Scanner

As of Sep 09, 2026
example chart graphic
Scan Name: Undervalued StocksScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Undervalued Blue ChipsScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Falling WedgeScan Type: Chart Pattern Scans
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.